花粉诱发季节性过敏性哮喘的临床与机制研究进展
Advances in the clinical and mechanism research of pollen induced seasonal allergic asthma.
作者信息
Xie Zhi-Juan, Guan Kai, Yin Jia
机构信息
Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100730, P.R. China.
Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment on Allergic Diseases Beijing 100730, P.R. China.
出版信息
Am J Clin Exp Immunol. 2019 Feb 15;8(1):1-8. eCollection 2019.
Abstract
Seasonal allergic asthma prevalence has been increasing over the last decades and is one of global health concerns now. Pollen is one of the main reasons to cause seasonal allergic asthma and influenced by multiple risk factors. Thunderstorm-related asthma is a typical type of seasonal allergic asthma that thunderstorms occurring can induce severe asthma attacks during pollen season. The diagnosis of seasonal allergic asthma relies on precise medical history, skin prick tests (SPT) and specific IgE detection. Component resolved diagnosis is greatly significant in determining the complex situation. Allergen specific immunotherapy (AIT) is the only disease-modifying therapy that can change the natural course from seasonal allergic rhinitis to seasonal allergic asthma.
摘要
在过去几十年中，季节性过敏性哮喘的患病率一直在上升，如今已成为全球健康问题之一。花粉是导致季节性过敏性哮喘的主要原因之一，且受多种风险因素影响。雷暴相关哮喘是季节性过敏性哮喘的一种典型类型，在花粉季节，雷暴的发生可诱发严重的哮喘发作。季节性过敏性哮喘的诊断依赖于精确的病史、皮肤点刺试验（SPT）和特异性IgE检测。组分解析诊断对于确定复杂情况具有重要意义。变应原特异性免疫疗法（AIT）是唯一一种可改变从季节性过敏性鼻炎到季节性过敏性哮喘自然病程的疾病改善疗法。
相似文献
1
Advances in the clinical and mechanism research of pollen induced seasonal allergic asthma.花粉诱发季节性过敏性哮喘的临床与机制研究进展
Am J Clin Exp Immunol. 2019 Feb 15;8(1):1-8. eCollection 2019.
3
[The immunological parameters and risk factors for pollen-induced allergic rhinitis and asthma].[花粉诱发的变应性鼻炎和哮喘的免疫学参数及危险因素]
Medicina (Kaunas). 2003;39(3):244-53.
4
Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.标准化质量草过敏免疫治疗片剂季节性起始的免疫效应和耐受性特征：在因草花粉引起的鼻结膜炎成人中进行的 III 期、多中心、随机、双盲、安慰剂对照试验。
Clin Ther. 2011 Jul;33(7):828-40. doi: 10.1016/j.clinthera.2011.06.006. Epub 2011 Jul 7.
5
A recombinant pollen adjuvanted Art v 1 protein-based vaccine treats allergic rhinitis and bronchial asthma using pre- and co-seasonal ultrashort immunotherapy regimens in sensitized mice.一种重组花粉佐剂 Art v 1 蛋白基疫苗，通过在致敏小鼠中使用预季和共季超短免疫治疗方案，治疗过敏性鼻炎和支气管哮喘。
Front Immunol. 2022 Nov 9;13:983621. doi: 10.3389/fimmu.2022.983621. eCollection 2022.
6
Effectiveness and safety of a glutaraldehyde-modified, L-tyrosine-adsorbed and monophosphoryl lipid A-Adjuvanted allergen immunotherapy in patients with allergic asthma sensitized to olive pollen: A retrospective, controlled real-world study.戊二醛修饰、L-酪氨酸吸附及单磷酰脂质A佐剂的变应原免疫疗法在对橄榄花粉致敏的过敏性哮喘患者中的有效性和安全性：一项回顾性、对照的真实世界研究
World Allergy Organ J. 2020 Dec 18;13(12):100487. doi: 10.1016/j.waojou.2020.100487. eCollection 2020 Dec.
7
Non-specific airway hyperresponsiveness in mono-sensitive Sicilian patients with allergic rhinitis. Its relationship to total serum IgE levels and blood eosinophils during and out of the pollen season.患有过敏性鼻炎的单敏西西里患者的非特异性气道高反应性。其在花粉季节期间及非花粉季节与血清总IgE水平和血液嗜酸性粒细胞的关系。
Clin Exp Allergy. 1997 Sep;27(9):1052-9. doi: 10.1111/j.1365-2222.1997.tb01257.x.
8
Thunderstorm allergy and asthma: state of the art.雷暴与过敏及哮喘：最新进展
Multidiscip Respir Med. 2021 Dec 2;16(1):806. doi: 10.4081/mrm.2021.806. eCollection 2021 Jan 15.
9
Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.在接受超快速（20分钟）舌下免疫治疗并经组分解析诊断筛选的过敏患者中，全身副作用与对rPar j 2致敏之间的可能关系。
Int Arch Allergy Immunol. 2005 Oct;138(2):105-10. doi: 10.1159/000088431. Epub 2005 Sep 19.
10
How Do Storms Affect Asthma?风暴如何影响哮喘？
Curr Allergy Asthma Rep. 2018 Mar 24;18(4):24. doi: 10.1007/s11882-018-0775-9.
引用本文的文献
1
Modern Comprehensive Metabolomic Profiling of Pollen Using Various Analytical Techniques.利用多种分析技术对花粉进行现代综合代谢组学分析
Molecules. 2025 Mar 5;30(5):1172. doi: 10.3390/molecules30051172.
2
Methylation-driven mechanisms of allergic rhinitis during pollen and non-pollen seasons using integrated bioinformatics analysis.利用综合生物信息学分析研究花粉季和非花粉季期间变应性鼻炎的甲基化驱动机制。
Front Genet. 2024 Apr 18;15:1242974. doi: 10.3389/fgene.2024.1242974. eCollection 2024.
3
Pulmonary Function Tests in Thunderstorm-associated Respiratory Symptoms: A Cross-sectional Study.雷暴相关呼吸症状的肺功能测试：一项横断面研究。
Iran J Med Sci. 2024 Jan 1;49(1):40-45. doi: 10.30476/ijms.2023.96337.2784. eCollection 2024 Jan.
4
[Unmet Needs in Severe Allergic Asthma].[重度过敏性哮喘的未满足需求]
Open Respir Arch. 2023 Nov 1;5(4):100282. doi: 10.1016/j.opresp.2023.100282. eCollection 2023 Oct-Dec.
5
Clinical and experimental treatment of allergic asthma with an emphasis on allergen immunotherapy and its mechanisms.过敏性哮喘的临床与实验治疗，侧重于过敏原免疫治疗及其机制。
Clin Exp Immunol. 2023 Apr 7;212(1):14-28. doi: 10.1093/cei/uxad031.
6
Allergen Management in Children with Type 2-High Asthma.2型重度哮喘患儿的变应原管理
J Asthma Allergy. 2022 Mar 29;15:381-394. doi: 10.2147/JAA.S276994. eCollection 2022.
7
Seasonal Variation in miR-328-3p and let-7d-3p Are Associated With Seasonal Allergies and Asthma Symptoms in Children.miR-328-3p和let-7d-3p的季节性变化与儿童季节性过敏和哮喘症状相关。
Allergy Asthma Immunol Res. 2021 Jul;13(4):576-588. doi: 10.4168/aair.2021.13.4.576.
8
Allergenicity assessment of pollen grain and identification of allergens by immunoproteomic approach.采用免疫蛋白质组学方法对花粉粒进行致敏性评估及过敏原鉴定。
Heliyon. 2021 Feb 11;7(2):e06014. doi: 10.1016/j.heliyon.2021.e06014. eCollection 2021 Feb.
9
Association Between Changes in Timing of Spring Onset and Asthma Hospitalization in Maryland.马里兰州春季开始时间变化与哮喘住院之间的关联。
JAMA Netw Open. 2020 Jul 1;3(7):e207551. doi: 10.1001/jamanetworkopen.2020.7551.
10
Clinical Efficacy Evaluation of 1-Year Subcutaneous Immunotherapy for Pollen Allergic Rhinitis by Serum Metabolomics.血清代谢组学评估皮下注射免疫疗法治疗花粉过敏性鼻炎1年的临床疗效
Front Pharmacol. 2020 Mar 18;11:305. doi: 10.3389/fphar.2020.00305. eCollection 2020.
本文引用的文献
1
How Do Storms Affect Asthma?风暴如何影响哮喘？
Curr Allergy Asthma Rep. 2018 Mar 24;18(4):24. doi: 10.1007/s11882-018-0775-9.
2
ILC2 frequency and activity are inhibited by glucocorticoid treatment via STAT pathway in patients with asthma.哮喘患者中，糖皮质激素通过 STAT 通路抑制 ILC2 的频率和活性。
Allergy. 2018 Sep;73(9):1860-1870. doi: 10.1111/all.13438.
3
External exposome and allergic respiratory and skin diseases.外暴露组与过敏性呼吸和皮肤疾病。
J Allergy Clin Immunol. 2018 Mar;141(3):846-857. doi: 10.1016/j.jaci.2018.01.016.
4
Interventions for autumn exacerbations of asthma in children.儿童秋季哮喘加重的干预措施。
Cochrane Database Syst Rev. 2018 Mar 8;3(3):CD012393. doi: 10.1002/14651858.CD012393.pub2.
5
induction of T regulatory cells by a methylated CpG DNA sequence in humans: Potential therapeutic applications in allergic and autoimmune diseases.人源甲基化CpG DNA序列诱导调节性T细胞：在变应性和自身免疫性疾病中的潜在治疗应用
Allergy Asthma Proc. 2018 Mar 1;39(2):143-152. doi: 10.2500/aap.2018.39.4113.
6
Modified Allergens for Immunotherapy.变应原免疫治疗。
Curr Allergy Asthma Rep. 2018 Feb 16;18(2):9. doi: 10.1007/s11882-018-0766-x.
7
TGF-β-Induced CD8CD103 Regulatory T Cells Show Potent Therapeutic Effect on Chronic Graft-versus-Host Disease Lupus by Suppressing B Cells.TGF-β 诱导的 CD8CD103 调节性 T 细胞通过抑制 B 细胞对慢性移植物抗宿主病狼疮发挥强大的治疗作用。
Front Immunol. 2018 Jan 30;9:35. doi: 10.3389/fimmu.2018.00035. eCollection 2018.
8
EAACI guidelines on allergen immunotherapy: Executive statement.欧洲变态反应和临床免疫学会变应原免疫治疗指南：执行声明
Allergy. 2018 Apr;73(4):739-743. doi: 10.1111/all.13420.
9
Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32.基于重组 B 细胞表位的草花粉疫苗 BM32 的免疫治疗的安全性和有效性。
J Allergy Clin Immunol. 2018 Aug;142(2):497-509.e9. doi: 10.1016/j.jaci.2017.09.052. Epub 2018 Jan 17.
10
Stormy weather: a retrospective analysis of demand for emergency medical services during epidemic thunderstorm asthma.暴风雨天气：流行性雷暴性哮喘期间紧急医疗服务需求的回顾性分析
BMJ. 2017 Dec 13;359:j5636. doi: 10.1136/bmj.j5636.
Zotero 插件